Keyword :   chronic myeloid leukemia

33928905235Inhibition of USP1, a new partner of Bcr-Abl, results in decrease of Bcr-Abl level in K562 cells
Authors :Antonenko S.V.* Telegeev G.D. Date: 2020-06-26 / Views: 80
Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy
Authors :Perekhrestenko T.* Melnyk U. Goryainova N. Diagil I. Date: 2020-06-25 / Views: 85
3523532523253Aberrant expression of placental-like alkaline phosphatase in chronic myeloid leukemia cells in vitro and its modulation by vitamin E
Authors :Shvachko L.P.* Zavelevich M.P. Gluzman D.F. Telegeev G.D. Date: 2020-03-31 / Views: 168
3202395023523Vitamin Е activates expression of С/EBP alpha transcription factor and G-CSF receptor in leukemic K562 cells
Authors :Shvachko L.P.* Zavelevich M.P.* Gluzman D.F. Kravchuk I.V.... Date: 2018-12-27 / Views: 421
5477Chronic myeloid leukemia in patient with the Klinefelter syndrome
Authors :Andreieva S.V.* Korets K.V. Kyselova O.A. Ruzhinska O.E.... Vol. 38, No. 3 / Views: 441
Functional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapyFunctional activity of CD34-positive cells in chronic myeloid leukemia patients with different response to imatinib therapy
Authors :Sviezhentseva I.O. Perekhrestenko T.P. Bilko D.I. Gordienko A.I.... Vol. 37, No. 1 / Views: 650
Determination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in cml-patients treated with tyrosine kinase inhibitorsDetermination of the optimal chemotherapy drugs pretreatment time through cultivation of hemopoietic cells in CML-patients treated with tyrosine kinase inhibitors
Authors :Zhaleiko I.O. Perekhrestenko T.P. Bilko D.I. Dyagil I.S.... Vol. 36, No. 2 / Views: 330
APPLICATION OF FISH TECHNIQUE FOR CYTOGENETIC ANALYSIS IN CHRONIC MYELOID LEUKEMIA PATIENTS
Authors :Kasakyan S. Tachdjian G. Movsessyan E. Dagbhashyan S.... Vol. 25, No. 1 / Views: 353